The MAMMAL Drug-Target Interaction API, available at POST /api/v1/mammal/dti, is a powerful tool within the free Cure Cancer With AI public API. This endpoint is designed to predict the binding affinity between drugs and their target proteins using advanced machine learning techniques. By providing a straightforward way to estimate how strongly a compound binds to a given target, this API addresses a critical challenge in the early stages of drug discovery.

Why This Endpoint Matters

Understanding the interaction between drugs and their targets is a fundamental aspect of drug development. The binding affinity, quantified as the negative logarithm of the dissociation constant (−log₁₀ Kd, or pKd), gives valuable insights into how effectively a drug may work against a specific biological target. Higher pKd values indicate stronger predicted binding, which is essential for prioritizing compounds in the drug discovery pipeline.

Before even entering the lab, researchers can use the MAMMAL API to quickly evaluate the potential effectiveness of various compounds through computational predictions. This not only accelerates the research process but also conserves resources by allowing researchers to triage which compounds to advance in the discovery workflow.

How to Use It

Using the MAMMAL Drug-Target Interaction API is straightforward. The API accepts a POST request at the path /api/v1/mammal/dti and requires a JSON body with specific parameters:

• target_seq: The amino acid sequence of the target protein.
• drug_seq: The SMILES representation of the drug compound.
• norm_y_mean (optional): Override for normalization mean.
• norm_y_std (optional): Override for normalization standard deviation.

The API will respond with a JSON object containing the predicted binding affinity:

{
    "data": {
        "pKd": 7.45 // Example value
    }
}

Here’s a sample curl command to demonstrate how to use this endpoint:

curl -X POST https://curecancerwithai.com/api/v1/mammal/dti \
-H "Authorization: Bearer ccw_live_YOUR_KEY" \
-H "Content-Type: application/json" \
-d '{
    "target_seq": "MKTAYIAKQRQISFVKSHFSRQD",
    "drug_seq": "CC(=O)OC1=CC=CC=C1C(=C(C)O)C(=O)O"
}'

In this example, replace YOUR_KEY with your actual API key. The request includes the protein sequence and drug SMILES notation, and the response will provide the predicted pKd value.

What You Can Build

The MAMMAL Drug-Target Interaction API opens up numerous possibilities for researchers and developers:

• Compound Library Ranking: Use the API to evaluate and rank a library of compounds against a specific target protein, helping to identify the most promising candidates for further study.
• Hit Triage: Quickly assess and filter hits from high-throughput screening assays before committing to more costly and time-consuming experiments.
• Discovery Pipeline Integration: Add binding affinity predictions as a signal in your drug discovery pipeline, enhancing decision-making processes and resource allocation.
• Research Tools: Develop applications or dashboards that provide visualizations of drug-target interactions, facilitating better insights for researchers.

Get Started for Free

The MAMMAL Drug-Target Interaction API is part of the broader free offerings from Cure Cancer With AI. You can create your free API key at /api-keys and start using the API immediately. With a free tier allowing for 100 requests per hour, it’s an accessible resource for researchers and developers alike. For detailed documentation and additional code samples, visit /developers.

Remember, the predictions generated by this API are meant for research purposes only and should not be considered as medical advice or a substitute for professional healthcare guidance. Always consult with qualified professionals regarding medical decisions.

Conclusion

The MAMMAL Drug-Target Interaction API provides a valuable resource for those working in oncology and drug discovery. By facilitating the prediction of drug-target binding affinities, this endpoint empowers researchers to make informed decisions earlier in the drug development process, ultimately contributing to the fight against cancer.

To dive deeper into practical AI-for-cancer-research updates, explore our latest blog posts, learn more about our mission, and see how you can support ongoing work on our donations page.